Product Description
The global elbow repair device market was valued at $235.4 million in 2024. This is expected to increase over the forecast period at a CAGR of 3.2% to reach $293.9 million.
The full report suite on the global market for elbow repair devices includes primary elbow implants, radial head implants and plates and screws for elbow repair.
MARKET DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ELBOW REPAIR DEVICES MARKET TRENDS
Growing demand for outpatient surgeries is accelerating adoption of minimally invasive elbow repair techniques, driven by cost-efficiency and faster recovery times. This shift is increasing procedural volumes and device demand.
GLOBAL ELBOW REPAIR DEVICES MARKET SHARE INSIGHTS
- DePuy Synthes competes primarily through its trauma-focused elbow solutions rather than total elbow arthroplasty systems. The company leverages its strong position in upper extremity trauma with comprehensive plating systems for distal humerus and radial head fractures. Its elbow strategy appears focused on capturing cases through the trauma pathway rather than elective arthroplasty, differentiating the company’s market approach from competitors.
- Zimmer Biomet holds the second-largest share of the elbow repair market. Nexel Total Elbow System, which offers both linked and unlinked configurations is one of the flagship products that the company offers. While demonstrating satisfactory long-term clinical outcomes, the system faces challenges in anatomical compatibility for certain patient demographics. Their radial head implant line benefits from integration with broader upper extremity solutions, though this creates dependencies on shoulder reconstruction market performance. The application of robotic technology to elbow procedures remains limited compared to other joint segments.
- Stryker’s Solar Elbow System represents the latest generation of convertible implants, enabling intraoperative transitions between linked and unlinked configurations. While the system offers theoretical advantages in surgical flexibility, real-world adoption has been tempered by the learning curve associated with convertible designs. Stryker’s trauma implants continue to benefit from the company’s broader orthopedics ecosystem, particularly in ambulatory surgery settings where streamlined workflows and integrated solutions are highly valued.
MARKET SEGMENTATION SUMMARY
- Primary Elbow Implants
- Radial Head Implants
- Plates and Screws
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2024 |
Forecast | 2025-2031 |
Historical Data | 2021-2023 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.